The Two Faces of #PTSD: Fear vs. Emotional Pain. Our new research in Biological Psychiatry @biologicalpsych.bsky.social identifies distinct clinical & neural profiles.
AI says no one reads long papers, so we made an infographic!👇
Full Paper (for the insistents😉): doi.org/10.1016/j.bi...
NEW TEN-PART AUDIO SERIES about #PSYCHEDELICS
Out now on BBC Sounds - and other podcast spaces.
Co-written & presented by the beautifully curious @timhayward.bsky.social
Production, sound design and mix by me.
It's been a fascinating and challenging process to get here...
I do hope you'll listen.
The emotional architecture of the psychedelic
brain: If you are interested in #psychedelics and #emotions, take a look at our new paper: authors.elsevier.com/sd/article/S.... With Flora Moujaes, @nathalierieser.bsky.social, Lydia Belinger, Marcus Herdener, & Zarmeen Zahid. Just published in TICS.
🧵 How do psychedelics shape brain activity?
Our new paper presents the largest neuroimaging study of psilocybin to date—revealing how context structures psychedelic brain states.
Title: Psychedelics Align Brain Activity with Context
Paper: lnkd.in/gt-kMR6d
A thread 🧵👇 1/n
Absolutely, there was a lot going on at that time.
Above all, this study highlights that more research is needed to find out who is most likely to benefit from psychedelic-assisted therapy and what constitutes the best therapeutic model. For more details, take a look at the publication (open access): www.sciencedirect.com/science/arti....
There may be many reasons for this, including the small sample size and the severity of AUD in our population. It is possible that achieving sustained benefits requires a more intensive pharmaco-psychotherapeutic approach than was implemented in this study.
We tested a single dose of psilocybin for relapse prevention in alcohol use disorder. As you may notice, this is not another success story for psychedelic-assisted therapy. Contrary to our hypothesis, we did not find any differences between the psilocybin and placebo group on our primary outcomes.
Hi everyone, if you are interested in #psychedelic-assisted therapy, we just published a new study: www.sciencedirect.com/science/arti.... Congratulations to Dr. Nathalie Rieser, who has done a terrific job spearheading this project.
📣📣📣 I am very happy to announce the first edition of the National Symposium of the #Psychedelic Medicine Section of the #AFPBN, taking place on Thursday, June 5th, 2025, at the Paris Brain Institute.
www.afpbn.org/1st-national...
🎓 Announcing Dr Katrin Preller! 🎓
@katrinpreller.bsky.social - leading researcher in psychedelic neuropsychopharmacology - will be teaching in @MonashUni’s *Psychedelic Science: Fundamentals to Frontiers* course.
📢 Starts Feb
ENROL: www.monash.edu/psychedelic-science
#PsychedelicEducation
Hi everyone, we have published a new paper showing that #psilocybin increases emotional #empathy in patients living with depression for at least two weeks after a single administration. If you are interested in #psychedelics and #social cognition, take a look here: www.nature.com/articles/s41...
#SpecialIssue in the FENS journal, EJN - European Journal of Neuroscience! "New trends in the empirical study of #consciousness: Measures and mechanisms"
doi.org/10.1111/ejn....
image: Nicolas Decat "Reflections of consciousness"
#FENS #EJN
@thomasandrillon.bsky.social @katrinpreller.bsky.social